Navigation Links
CellCyte Genetics Corporation Selects Washington University School of Medicine to Perform Study on CellCyte's Glycoprotein Products in Heart Attack Disease Model
Date:6/3/2008

BOTHELL, Wash., June 3 /PRNewswire-FirstCall/ -- CellCyte Genetics Corporation (CellCyte) (OTC Bulletin Board: CCYG) has selected the Cardiovascular Phenotyping Core at Washington University School of Medicine in St. Louis to perform a study to further evaluate CellCyte's glycoprotein products. The goal of the study is to investigate the efficiency of CellCyte's glycoprotein products in a preclinical model of myocardial infarction (heart attack).

"We look forward to working with the scientific team at Washington University on this study, which will continue to advance the research and development efforts for our glycoprotein products," noted Ronald W. Berninger, Ph.D., Chief Scientific Officer at CellCyte. "These are highly experienced researchers, as demonstrated by the fact that they perform more than 6,000 surgical and imaging procedures annually. Outsourcing a portion of the preclinical work allows us to move our program forward more quickly and is complementary to our in-house scientific efforts," Berninger added.

About the Washington University School of Medicine

Washington University School of Medicine's 2,100 employed and volunteer faculty physicians also are the medical staff of Barnes-Jewish and St. Louis Children's Hospitals. The School of Medicine is one of the leading medical research, teaching, and patient care institutions in the nation, currently ranked third in the nation by U.S. News & World Report. Through its affiliations with Barnes-Jewish and St. Louis Children's Hospitals, the School of Medicine is linked to BJC HealthCare.

About CellCyte Genetics

CellCyte Genetics is a biotechnology company engaged in the discovery, development and commercialization of stem cell enabling therapeutic products. CellCyte is developing products to allow more efficient delivery and increased retention of adult stem cells to diseased organs, such as the heart. The goal of these therapies is to increase the number of stem ce
'/>"/>

SOURCE CellCyte Genetics Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CellCyte Genetics Signs Collaborative Agreement With Northwestern Universitys Feinberg School of Medicine to Perform Disease Model Outcome Study of CellCytes CCG-TH30 Product Candidate
2. CellCyte Genetics Corp. Enters Collaborative Research Agreement With Cleveland Clinic Foundation to Qualify Stem Cell Delivery in Damaged Heart Tissue
3. Video: The Journal, Human Genetics, Publishes Results Supporting Interleukin Genetics Heart Health Test
4. Genzyme Genetics Announces Launch of Carrier Testing and Prenatal Diagnosis for Spinal Muscular Atrophy
5. deCODE Obesity Study Sheds Light on How Genetics Affects Risk and Onset of Common Diseases
6. ZymoGenetics Reports Positive Phase 1 Results for IL-21 With Nexavar(R)
7. Groundbreaking Study Proves Personalized Diet Based on Genetics Leads to Significant Advances in Long Term Weight Management and Blood Glucose Levels
8. Targeted Genetics Reports on Recombinant DNA Advisory Committee (RAC) Review of its Phase 1/2 Trial of tgAAC94 for Rheumatoid Arthritis
9. Genetics Determine Optimal Drug Dose of Common Anticoagulant
10. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
11. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... -- Varian Medical Systems (NYSE: VAR) today broke ground on new ... City manufacturing facility and allow for the consolidation ... to ultimately create 1,000 new full time jobs in ... " Utah is home to hardworking people ... be credited with Varian,s success in the manufacturing of our ...
(Date:8/27/2014)... Fla. , Aug. 27, 2014 By now, ... you,re likely not living on this planet. The awareness campaign ... consciousness and has helped to raise over $88.5 Million (and ... getting involved and some companies are starting to as well. ... Orlando, Florida , who actually works with ...
(Date:8/27/2014)... -- Hill-Rom Holdings, Inc. (NYSE: HRC ) invites ... Morgan Stanley Global Healthcare Conference on September 8, 2014, ... to listen to the live discussion via the internet ... at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of the ... the live event and accessible at the links above ...
Breaking Medicine Technology:Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 2Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 3Varian Medical Systems Groundbreaking on Facility Expansion Triggers Influx of New Jobs to Salt Lake 4Acorn Stairlifts Gives a Lift to the ALS Ice Bucket Challenge 2
... Foundation Fighting Blindness ... Medicine, OWINGS MILLS, Md., April 27 Scientists employing ... nearly blind from,a condition known as Leber congenital amaurosis (LCA) ... clinical trial, which was,funded in part by the Foundation Fighting ...
... treatments A promising ... way Improved ability to select ... , At today,s sessions of this, the final day ... Study of the Liver (EASL), leading,hepatologists described several important advances ...
Cached Medicine Technology:Gene Therapy Provides Vision to People who Were Nearly Blind 2Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC) 2Molecular Discoveries Shed Light on Liver Cancer -- Hepatocellular Carcinoma (HCC) 3
(Date:8/27/2014)... 2014 Power morcellator lawsuits ( http://www.gynecaremorcellatorlawsuit.com/ ... behalf of women who allegedly experienced the spread of ... reports. According to court documents, one of the most ... U.S. District Court, Northern District of New York, on ... of a power morcellator manufactured Karl Storz Endoscopy - ...
(Date:8/27/2014)... What’s next for 14 year old Sriram Hathwar, ... Spelling Bee? Sririam will visit Philadelphia on Friday, August ... Eye Hospital.     , The teen from Painted Post, New ... , Wills Eye Ophthalmologist-in-Chief, Dr. Julia Haller will show ... diagnostic testing. He will also tour historic Philadelphia ...
(Date:8/27/2014)... The newest Abington Health Center ... 8, 2014. This new 15,000 square foot, $5 million ... care practices and walk-in laboratory services. , ... endeavor for Abington Health as the healthcare landscape changes,” ... “Establishing a location in Lower Gwynedd allows us to ...
(Date:8/27/2014)... -- Overconfident people are better at convincing others that ... are more likely to get promotions and reach high-level ... that these "self-deceived" people are also more likely to ... And finally, people who underestimate themselves are regarded ... British researchers. Their findings were published Aug. 27 in ...
(Date:8/27/2014)... Recent growth in health care spending for commercially ... for medical services, rather than increased use, according to ... Institute for Health Policy & Clinical Practice, published in ... Managed Care . , There is increasing concern that ... increased prices faced by payers and, ultimately, consumers," said ...
Breaking Medicine News(10 mins):Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 2Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 3Health News:Power Morcellator Lawsuit Alleges Storz Morcellator Caused Spread of Aggressive Uterine Cancer, Bernstein Liebhard LLP Reports 4Health News:Scripps National Spelling Bee Co-Champion and Aspiring Ophthalmologist Coming to Wills Eye Hospital in Philadelphia 2Health News:Abington Health Opens New Health Center in Lower Gwynedd 2Health News:Overconfident Folks May Blind Others to Their Real Abilities 2Health News:Tracking spending among the commercially insured 2
... Lancet Neurology says that the fact that first-borns have a ... myth. Birth order of the children does not increase their ... // have any affect on the incidence of multiple sclerosis., ... a role in MS. Previous research has reported a higher ...
... A new study indicates that a combination of surgery ... patients suffering from spinal cord compression. //, ,Metastatic ... common complication of cancer, occurring in 5 to 14 ... of corticosteroids and radiotherapy - after which only 50 ...
... also been under intense scrutiny to look at their ... and 25 other related conditions) and HIV. // , ... lover of all, Casanova in the 17th century was ... against infection. The question now is that how much ...
... the genetic pathway involved in the development of hearing. Research ... ear –– the cells largely responsible for hearing // ... ,Situated in the hearing portion of the inner ... the ear in the form of sound waves into chemical ...
... claimed at least 20 lives in the past two weeks ... already present in the neighboring Indian state of UP // ... 10 deaths each in the townships of Tikapur and Dhangadi ... 80 patients were undergoing treatment in various hospitals and health ...
... slowly spreading in UP and causing more deaths especially in ... caused by the rapidly spreading killer virus // in ... disease was so far confined largely to Gorakhpur and neighboring ... only nearby Bahraich, Barabanki and Lakhimpur-Kheri districts but also to ...
Cached Medicine News:Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 2Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 3Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 4Health News:Encephalitis Claims 131 lives in Uttar Pradesh 2
Liquichek Pediatric Control is a product designed to monitor important analytes for neonatal testing. This control monitors four bilirubin parameters at two clinically significant levels....
... Chemistry Control (Human) provides a comprehensive ... enzymes and CO2. It requires no ... most major instruments and methodologies. Available ... fill sizes (10 mL fill size ...
Liquid Assayed and Unassayed Multiqual Controls are comprehensive, liquid, human serum based chemistry controls, available in three levels....
Lyphochek® Drug Free Serum can serve as a drug-free baseline for HPLC analysis or as a negative control....
Medicine Products: